{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:31:11Z","timestamp":1787027471989,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M782208"],"award-info":[{"award-number":["2025M782208"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20255001"],"award-info":[{"award-number":["BK20255001"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004610","name":"Science and Technology Support Program of Jiangsu Province","doi-asserted-by":"publisher","award":["BZ2025036"],"award-info":[{"award-number":["BZ2025036"]}],"id":[{"id":"10.13039\/501100004610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2325019"],"award-info":[{"award-number":["T2325019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mtbio.2026.103355","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:12:47Z","timestamp":1781309567000},"page":"103355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multi-payload antibody-drug conjugates for photothermal dynamic and chemotherapy of HER2-positive breast cancer"],"prefix":"10.1016","volume":"39","author":[{"given":"Yuqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzhong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2234-9126","authenticated-orcid":false,"given":"Haibin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103355_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ctrv.2017.10.005","article-title":"The clinical development of vaccines for HER2+ breast cancer: current landscape and future perspectives","volume":"61","author":"Costa","year":"2017","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.mtbio.2026.103355_bib2","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1158\/1078-0432.CCR-18-2381","article-title":"Intracellular delivery of an antibody targeting Gasdermin-B reduces HER2 breast cancer aggressiveness","volume":"25","author":"Molina-Crespo","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103355_bib3","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.e12059","article-title":"Outcomes related to delayed initiation of anti-HER 2 therapy in pregnant HER2 positive breast cancer patients","volume":"35","author":"Oke","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103355_bib4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mtbio.2026.103355_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41571-023-00854-y","article-title":"Pyrotinib in combination with first-line trastuzumab and docetaxel for patients with HER2-positive metastatic breast cancer: a new therapeutic option?","volume":"21","author":"Berton Giachetti","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103355_bib6","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1038\/s41467-025-61213-2","article-title":"Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial","volume":"16","author":"Niu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103355_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-019-0268-3","article-title":"HER2-targeted therapies-a role beyond breast cancer","volume":"17","author":"Oh","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103355_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-Positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mtbio.2026.103355_bib9","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2025-6746","article-title":"Abstract 6746: multi-modal assessment of an anti-HER2 (trastuzumab) antibody-drug conjugate screening assay for breast cancer models","volume":"85","author":"Steffey","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103355_bib10","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.e13006","article-title":"STAT6 expression and trastuzumab resistance in HER2+ breast cancer","volume":"38","author":"Cobleigh","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103355_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13046-018-0875-3","article-title":"Retracted ARTICLE: SP1-Induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88","volume":"37","author":"Dong","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103355_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41419-020-2250-5","article-title":"Retracted article: exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer","volume":"11","author":"Han","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mtbio.2026.103355_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12943-020-01283-6","article-title":"A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer","volume":"19","author":"Park","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2026.103355_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41392-021-00629-w","article-title":"Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab","volume":"6","author":"Zheng","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2026.103355_bib15","article-title":"Real-Life experience of HER2 (human epidermal growth factor receptor 2)-Positive advanced breast cancer patients treated with T-DXd (Trastuzumab deruxtecan): a multicentric Portuguese Study","volume":"17","author":"Bizarro","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.mtbio.2026.103355_bib16","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1038\/s41591-024-03021-7","article-title":"Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial","volume":"30","author":"Cort\u00e9s","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.mtbio.2026.103355_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-023-00779-6","article-title":"T-DXd is effective after T-DM1","volume":"20","author":"Sidaway","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103355_bib18","article-title":"Molecular stacking composite nanoparticles of gossypolone and thermodynamic agent for elimination of large tumor in mice via electrothermal-thermodynamic-chemo trimodal combination therapy","volume":"32","author":"Liu","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2026.103355_bib19","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1002\/anie.201702898","article-title":"A hybrid nanomaterial for the controlled generation of free radicals and oxidative destruction of hypoxic cancer cells","volume":"56","author":"Shen","year":"2017","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.mtbio.2026.103355_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101073","article-title":"Near-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy","volume":"37","author":"Sun","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.mtbio.2026.103355_bib21","doi-asserted-by":"crossref","first-page":"9029","DOI":"10.1002\/anie.201703159","article-title":"Initiator-loaded gold nanocages as a light-induced free-radical generator for cancer therapy","volume":"56","author":"Wang","year":"2017","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.mtbio.2026.103355_bib22","doi-asserted-by":"crossref","first-page":"13144","DOI":"10.1021\/acsnano.9b05985","article-title":"Hyperthermia and controllable free radical coenhanced synergistic therapy in hypoxia enabled by Near-Infrared-II light irradiation","volume":"13","author":"Yang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103355_bib23","article-title":"Metal-organic framework (MOF)-based ultrasound-responsive dual-sonosensitizer nanoplatform for hypoxic cancer therapy","volume":"11","author":"Zhang","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2026.103355_bib24","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1016\/j.cclet.2022.03.023","article-title":"Building multipurpose nano-toolkit by rationally decorating NIR-II fluorophore to meet the needs of tumor diagnosis and treatment","volume":"33","author":"Cui","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.mtbio.2026.103355_bib25","doi-asserted-by":"crossref","first-page":"12857","DOI":"10.1021\/acsami.0c22555","article-title":"Smart On-Site immobilizable near-infrared II fluorescent nanoprobes for ultra-long-term imaging-guided tumor surgery and photothermal therapy","volume":"13","author":"Zhang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2026.103355_bib26","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1039\/C9NR10720G","article-title":"A novel alpha(v)beta(3) integrin-targeted NIR-II nanoprobe for multimodal imaging-guided photothermal therapy of tumors in vivo","volume":"12","author":"Zhao","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.mtbio.2026.103355_bib27","article-title":"Self-regenerating photothermal agents for tandem photothermal and thermodynamic tumor therapy","volume":"9","author":"Li","year":"2025","journal-title":"Small Methods"},{"key":"10.1016\/j.mtbio.2026.103355_bib28","article-title":"A biocompatible free radical nanogenerator with real-time monitoring capability for high performance sequential hypoxic tumor therapy","volume":"29","author":"Wan","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2026.103355_bib29","doi-asserted-by":"crossref","first-page":"34436","DOI":"10.1021\/acsami.3c04354","article-title":"Injectable hydrogel containing TiO nanosheets for synergistic photothermal\/Thermodynamic therapy","volume":"15","author":"Xing","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2026.103355_bib30","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jcis.2025.01.257","article-title":"Thermo-responsive and biodegradable MoS2-based nanoplatform for tumor therapy and postoperative wound management","volume":"686","author":"Yin","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.mtbio.2026.103355_bib31","article-title":"Engineering asymmetric electronic structures in Fe-N-S-C nanozymes for dual enzyme-catalyzed-induced ferroptosis and enhanced antitumor efficacy","volume":"37","author":"Yu","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.mtbio.2026.103355_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102498","article-title":"Photoferroptosis as a potent strategy for neuroblastoma treatment","volume":"59","author":"Zhang","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.mtbio.2026.103355_bib33","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1021\/jacs.1c07675","article-title":"Single mutation on trastuzumab modulates the stability of antibody\u2013drug conjugates built using acetal-based linkers and thiol-maleimide chemistry","volume":"144","author":"Ferhati","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mtbio.2026.103355_bib34","article-title":"Precise HER2 protein degradation via peptide-conjugated photodynamic therapy for enhanced breast cancer immunotherapy","volume":"12","author":"Guo","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mtbio.2026.103355_bib35","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41467-023-44533-z","article-title":"The HER2-directed antibody-drug conjugate DHES0815A in advanced and\/or metastatic breast cancer: preclinical characterization and phase 1 trial results","volume":"15","author":"Lewis","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103355_bib36","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2025-4314","article-title":"Abstract 4314: understanding the mode of action and development of resistance towards HER2 targeting agents in preclinical in vivo models","volume":"85","author":"Oswald","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103355_bib37","doi-asserted-by":"crossref","first-page":"19221","DOI":"10.1021\/jacs.9b10043","article-title":"J-Aggregates of Cyanine dye for NIR-II in vivo dynamic vascular Imaging beyond 1500 nm","volume":"141","author":"Sun","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mtbio.2026.103355_bib38","article-title":"NIR-II J-Aggregates labelled mesoporous implant for imaging-guided osteosynthesis with minimal invasion","volume":"31","author":"Sun","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2026.103355_bib39","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41467-025-56691-3","article-title":"Stimulus-activated ribonuclease targeting chimeras for tumor microenvironment activated cancer therapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426006009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426006009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:23Z","timestamp":1787026943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426006009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"alternative-id":["S2590006426006009"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103355","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-payload antibody-drug conjugates for photothermal dynamic and chemotherapy of HER2-positive breast cancer","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103355"}}